For a Healio article highlighting the FDA approval of sotatercept, a drug to treat pulmonary arterial hypertension (PAH), Mario Naranjo-Tovar, MD, MHS, Assistant Professor of Thoracic Medicine & Surgery at the Lewis Katz School of Medicine at Temple University, provided perspective on what this decision means for patients, as well as its impact on the future of care for PAH.
Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.
myTempleHealth
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH